214 related items for PubMed ID: 10531156
21. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in healthy volunteers.
Mackie AE, McDowall JE, Falcoz C, Ventresca P, Bye A, Daley-Yates PT.
Clin Pharmacokinet; 2000; 39 Suppl 1():23-30. PubMed ID: 11140430
[Abstract] [Full Text] [Related]
22. Cost-effectiveness of fluticasone propionate administered via metered-dose inhaler plus babyhaler spacer in the treatment of asthma in preschool-aged children.
Bisgaard H, Price MJ, Maden C, Olsen NA.
Chest; 2001 Dec; 120(6):1835-42. PubMed ID: 11742910
[Abstract] [Full Text] [Related]
23. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
Ayres JG, Millar AB, Sykes AP.
Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
[Abstract] [Full Text] [Related]
24. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids.
Wilson AM, Lipworth BJ.
Thorax; 1999 Jan; 54(1):20-6. PubMed ID: 10343626
[Abstract] [Full Text] [Related]
25. Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler.
Thorsson L, Edsbäcker S, Källén A, Löfdahl CG.
Br J Clin Pharmacol; 2001 Nov; 52(5):529-38. PubMed ID: 11736861
[Abstract] [Full Text] [Related]
26. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
Clark DJ, Clark RA, Lipworth BJ.
Thorax; 1996 Sep; 51(9):941-3. PubMed ID: 8984708
[Abstract] [Full Text] [Related]
27. Significant variability in response to inhaled corticosteroids for persistent asthma.
Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, Craig TJ, Dolovich M, Drazen JM, Fagan JK, Fahy JV, Fish JE, Ford JG, Israel E, Kiley J, Kraft M, Lazarus SC, Lemanske RF, Mauger E, Peters SP, Sorkness CA, Asthma Clinical Research Network of the National Heart Lung, and Blood Institute.
J Allergy Clin Immunol; 2002 Mar; 109(3):410-8. PubMed ID: 11897984
[Abstract] [Full Text] [Related]
28. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics.
Wilson AM, McFarlane LC, Lipworth BJ.
Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1274-7. PubMed ID: 9351634
[Abstract] [Full Text] [Related]
29. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
Brutsche MH, Brutsche IC, Munawar M, Langley SJ, Masterson CM, Daley-Yates PT, Brown R, Custovic A, Woodcock A.
Lancet; 2000 Aug 12; 356(9229):556-61. PubMed ID: 10950233
[Abstract] [Full Text] [Related]
30. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.
Harrison TW, Wisniewski A, Honour J, Tattersfield AE.
Thorax; 2001 Mar 12; 56(3):186-91. PubMed ID: 11182010
[Abstract] [Full Text] [Related]
31. Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant.
Mackie AE, McDowall JE, Ventresca P, Bye A, Falcoz C, Daley-Yates PT.
Clin Pharmacokinet; 2000 Mar 12; 39 Suppl 1():17-22. PubMed ID: 11140429
[Abstract] [Full Text] [Related]
32. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study.
Bisgaard H, Gillies J, Groenewald M, Maden C.
Am J Respir Crit Care Med; 1999 Jul 12; 160(1):126-31. PubMed ID: 10390389
[Abstract] [Full Text] [Related]
33. Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate.
Fardon TC, Lee DK, Haggart K, McFarlane LC, Lipworth BJ.
Am J Respir Crit Care Med; 2004 Nov 01; 170(9):960-6. PubMed ID: 15184207
[Abstract] [Full Text] [Related]
34. Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients.
Clark DJ, Grove A, Cargill RI, Lipworth BJ.
Thorax; 1996 Mar 01; 51(3):262-6. PubMed ID: 8779128
[Abstract] [Full Text] [Related]
35. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler.
Grahnén A, Jansson B, Brundin RM, Ling-Andersson A, Lönnebo A, Johansson M, Eckernäs SA.
Eur J Clin Pharmacol; 1997 Mar 01; 52(4):261-7. PubMed ID: 9248762
[Abstract] [Full Text] [Related]
36. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan 01; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
37. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma.
Falcoz C, Horton J, Mackie AE, Harding SM, Daley-Yates PT.
Clin Pharmacokinet; 2000 Jan 01; 39 Suppl 1():31-7. PubMed ID: 11140431
[Abstract] [Full Text] [Related]
38. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
Derom E, Van Schoor J, Verhaeghe W, Vincken W, Pauwels R.
Am J Respir Crit Care Med; 1999 Jul 01; 160(1):157-61. PubMed ID: 10390394
[Abstract] [Full Text] [Related]
39. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
Derom E, Van De Velde V, Marissens S, Engelstätter R, Vincken W, Pauwels R.
Pulm Pharmacol Ther; 2005 Jul 01; 18(5):328-36. PubMed ID: 15939311
[Abstract] [Full Text] [Related]
40. Respirable dose delivery of fluticasone propionate from a small valved holding chamber, a compact breath actuated integrated vortex device and a metered dose inhaler.
Nair A, Menzies D, Barnes M, Burns P, McFarlane L, Lipworth BJ.
Br J Clin Pharmacol; 2008 Jul 01; 66(1):20-6. PubMed ID: 18341676
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
